Introduction
Few clinical trials have been performed to evaluate homoeopathic therapy (Aulas, 1985; Reilly et al., 1986 ). This situation is largely due to the rationale of homoeopathic prescription by which the precise nature of the treatment is adapted to the specific symptoms of a patient suffering from a given disease. The treatment is based on the 'simillimum' principle, using infinitesimal concentrations of drugs which have the ability to induce, in healthy individuals, symptoms similar to those presented by sick persons. Although a regular feature of homoeopathic treatment is that two patients who have the same disease are liable not to benefit from the same treatment, a school of thought soon developed (Finella, 1877) that certain diseases, especially some acute diseases, could be treated with substances or drug mixtures tailored to the disease characteristics alone.
Homoeopathic physicians are far from reaching agreement about such drugs, which would be prescribed without taking account of the particular symptoms of each patient. Nevertheless, these drugs are gaining popularity among large sections of the medical profession and among the public who buy them over-the-counter.
These preparations provide the opportunity to design conventional trials in a way that has not so far been possible with regular 'unitarian' drugs.
The following experiment deals with a drug of the former category. Its action on the treatment of influenza and influenza-like syndromes was evaluated. It is a homoeopathic preparation currently on the market, made of a highly diluted autolysate of animal organs.
Methods

Study design
The trial was implemented with the participation of general practitioners of the Rhone-Alpes region in France (regional capital: Lyon). Most of them were not homoeopathic clinicians. Patients included in the study were chosen from those who attended with influenza-like syndromes and who agreed to participate in the experiment after a formal briefing. The treatment allocation of active drug or placebo was made on a randomized double-blind basis. For the final evaluation a second visit to the physician's practice was planned for a week later.
Admission criteria
To be eligible patients had to be 12 years old and over, to suffer from an influenza-like syndrome defined by the association of a rectal temperature equal to or above 38°C, and at least two of the following symptoms: headache, stiffness, lumbar and articular pain, shivers. The first manifestation had to have occurred less than 24 h before entry.
Patients with immune deficiency or local infection were not included. Also excluded were those who had had immunization against influenza or who were under treatment either for depression or for stimulation of immunity.
Patients were asked not to take any drug for pain or fever during the 48 h following entry or, if they should do so, to record this use along with any use of antibiotics. The second information source was a local network of 12 sentinel practices monitored for the purpose of the study (Figure 1 ).
Study period
The A HlNl influenza virus was isolated in the study region 7 days after the study managers issued the instruction to start including patients in the experiment. Enrolment continued after the epidemic period, but 71% of all cases were entered during the peak of the epidemic. The study managers decided to include no further patients when it became apparent that the epidemic had ended. The main concern was to restrict the trial to those cases that were most likely to be cases of influenza. The standard treatment dispensed is one box containing five doses. The first dose was administered sublingually at the medical practice; the remaining four were taken on the following mornings and evenings. The doses were dispensed with a code number which was identified only after analysis of the data. Allocation of the active drug and placebo was balanced in every eight boxes. Each physician had to enrol between four and six patients.
Study diaries and monitoring
For 1 week patients noted morning and evening their temperature and the presence or absence of the five cardinal symptoms. Cough, coryza and fatigue were also recorded along with any use of medications or any side effects. Finally they were asked to make their own record of how effective they found the treatment to be.
Evaluation criteria
Recovery was defined as a rectal temperature less than 37.5°C and complete resolution of the five cardinal symptoms. Persistence of cough, coryza or fatigue was accepted. The main evaluation criteria set prior to data analysis were the recovery rate within 48 h of treatment (i.e. proportion of patients who had recovered within 48 h), and the time trend of this rate, as this gives insight into the consistency of the observed effect. Additional criteria were also examined e.g. the patients' judgement on the effectiveness of the treatment and whether any additional drug was taken.
Statistical analysis
Comparison of percentages were performed using Pearson's X . Adjustment for some identified or potential confounders was done by a Mantel-Haenszel procedure (Mantel, 1963) or by a multivariate logistic regression analysis. Crude data analysis was performed with a hand calculator using Rothman's programs (Rothman & Boice, 1984) . Confidence interval estimation followed Miettinen's method (1976) . The time trend analysis of the recovery rate (actuarial method) was performed with a logrank test (Mantel, 1966) This relative risk (RR) of recovery was 1.67
(95% CI 1.1-2.7, P = 0.03). The 'attributable fraction', which is the difference in the proportions of cases who recovered within 48 h, was 6.8% (95% CI 0.6-13%). The proportion of recoveries related to the active drug was greatest 36 h after treatment at 39.6% (95 CI 4-62%). Some parameters which were potential confounders of the association between the drug effect and recovery were included as covariates in a multivariate logistic regression model, as binary variables: age (< 30 years; : 30), period of entry (during the epidemic, after the epidemic), delay before treatment administration (< 12 h or 12-24 h after onset of symptoms), severity of the syndrome (moderate: < 390 C, two symptoms; intense: -39°C, three + symptoms), use of symptomatic drugs (against fever, pain, inflammation, cough or coryza) during the first 48 h (yes, no), antibiotic therapy (yes, no). Controlling for these covariates did not alter substantially the effect of the drug, which remained significant (OR = 1.9, 95% CI 1.1-3.4; P = 0.02). (In this setting, the Odds-Ratio (OR) is a reasonably good approximation of the relative risk). Interaction terms were tested and dropped from the model. In addition to the drug two other parameters showed significant association with recovery, namely age and severity of the syndrome at admission. Tables 3 and 4 give insight into these effects, showing that drug efficacy seems greater among younger patients (67.6% of recoveries within 48 h were related to Finally, the number of patients who made favourable judgements on the efficacy of the treatment was greater among the active drug group (61.2% against 49.3%; P = 0.02).
Discussion
Patients with an influenza-like syndrome who received the homoeopathic preparation showed Time (days) Figure 2 Actuarial recovery curve according to the treatment group (95% confidence interval) and proportion of recoveries related to the active drug (95% confidence interval). * * placebo group, *---active drug group, 0 -0 % recoveries related to the active drug. (Hannoun & Lhillier, 1987 (Hannoun & Lhillier, 1987) . The partitioning of the data set into 'old' and 'young' cases, with 30 years as the threshold, was decided during the data analysis with the aim of testing age effect in reasonably similar sample sizes. It was not conditioned by any prior hypothesis as to the immune status of older patients. However as the drug was more effective among patients aged less than 30 years, one might speculate that the action of Oscillococcinum® was more specifically active against the influenza virus. Clearly further studies are required to examine this possibility.
One earlier study was conducted with a small sample size and with a rather wide definition of influenza infection (Gassinger et al., 1981) . It showed no evidence of an effect of a homoeopathic substance as compared with acetylsalicylic acid. Another trial used a definition of influenzalike syndrome which was similar to the present study but did not reveal any preventive effect of a homoeopathic complex (Ferley et al., 1987) . Our study did not aim to evaluate the homoeopathic approach as a whole, but to test a specific preparation.
While pharmacological studies have been published recently (Cazin et al., 1987; Davenas et al., 1987 Davenas et al., , 1988 , conventional clinical trials published in the non-homoeopathic literature are exceptional (Reilly et al., 1986 ). Reviews : Scofield, 1984 stress the weakness of most homoeopathy trials and underline the methodological difficulties of such an enterprise. This tends to enhance the suspicion of those who are detractors of this therapeutic approach. Although it may be enjoying a revival among sections of the population at large and among part of the medical profession, only rigorous clinical experiments will allow vindication of this approach.
